XML 57 R4.htm IDEA: XBRL DOCUMENT v2.4.0.6
Condensed Consolidated Statements of Operations (USD $)
3 Months Ended 6 Months Ended
Jan. 31, 2013
Jan. 31, 2012
Jan. 31, 2013
Jan. 31, 2012
Net sales $ 74,577,000 $ 99,141,000 $ 165,530,000 $ 212,502,000
Cost of sales 42,337,000 57,725,000 91,487,000 119,806,000
Gross profit 32,240,000 41,416,000 74,043,000 92,696,000
Expenses:        
Selling, general and administrative 15,433,000 19,626,000 32,243,000 43,744,000
Research and development 9,278,000 9,444,000 19,327,000 19,128,000
Amortization of intangibles 1,582,000 1,692,000 3,164,000 3,411,000
Total operating expenses 26,293,000 30,762,000 54,734,000 66,283,000
Operating income 5,947,000 10,654,000 19,309,000 26,413,000
Other expenses (income):        
Interest expense 2,030,000 2,183,000 4,141,000 4,329,000
Interest income and other (315,000) (434,000) (591,000) (930,000)
Income before provision for income taxes 4,232,000 8,905,000 15,759,000 23,014,000
Provision for income taxes 1,867,000 3,084,000 5,959,000 4,592,000
Net income $ 2,365,000 $ 5,821,000 $ 9,800,000 $ 18,422,000
Net income per share:        
Basic $ 0.14 $ 0.29 $ 0.57 $ 0.85
Diluted $ 0.14 $ 0.27 $ 0.51 $ 0.75
Weighted average number of common shares outstanding - basic 17,300,000 20,087,000 17,340,000 21,672,000
Weighted average number of common and common equivalent shares outstanding - diluted 17,401,000 26,056,000 23,394,000 27,588,000
Dividends declared per issued and outstanding common share as of the applicable dividend record date $ 0.275 $ 0.275 $ 0.55 $ 0.55